ABINGDON, United Kingdom, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Gylden Pharma Limited (‘Gylden’ or the ‘Company’), a clinical-stage biotechnology company that is addressing major global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback